Lipid Nanoparticle Reactogenicity

Lipid Nanoparticle Reactogenicity is the inherent capacity of lipid nanoparticle-based delivery systems to induce localized or systemic immune activation and inflammatory responses following administration, distinguished from other vaccine adjuvanticity mechanisms by their structural and compositional dependence on synthetic lipid assemblies that interact with innate immune pathways.

8

Publications

310

Citations

129

Authors

32

Institutions

Publications per year

2017–2026

8

Authors

129

  1. KS
    Kongbrailatpam Shitaljit Sharma

    Oregon State University, United States

    1 publications · 43 citations

    1

    h-index

  2. BB
    Bram Bogaert

    Ghent University, Belgium

    1 publications · 31 citations

    1

    h-index

  3. CR
    Carlos R. Celis

    Instituto de Investigación Nutricional, Peru

    1 publications · 20 citations

    1

    h-index

  4. XZ
    Xianhuan Zeng

    China Pharmaceutical University, China

    1 publications · 32 citations

    1

    h-index

  5. YG
    Yingfei Gong

    Shandong University, China

    1 publications · 32 citations

    1

    h-index

1–5 of 129

Venues

  1. Emerging Microbes & Infections

    1 publications · 32 citations

    1

    h-index

  2. ACS Nano

    1 publications · 43 citations

    1

    h-index

  3. Vaccine X

    1 publications · 20 citations

    1

    h-index

  4. Journal of Allergy and Clinical Immunology

    1 publications · 96 citations

    1

    h-index

  5. Advanced Functional Materials

    1 publications · 31 citations

    1

    h-index

1–5